European Journal of Pharmacology, Journal Year: 2023, Volume and Issue: 964, P. 176295 - 176295
Published: Dec. 26, 2023
Language: Английский
European Journal of Pharmacology, Journal Year: 2023, Volume and Issue: 964, P. 176295 - 176295
Published: Dec. 26, 2023
Language: Английский
Frontiers in Nutrition, Journal Year: 2024, Volume and Issue: 11
Published: Jan. 23, 2024
The Fasting-Mimicking Diet (FMD) is a nutritional strategy that involves significantly reducing calorie intake for specific period to mimic the physiological effects of fasting while still providing body with nutrition. Our study aimed conduct bibliometric explore latest publishing trends and areas intense activity within sphere FMD. We extracted data on FMD publications from Web Science Core Collection (WOSCC) database. analysis was conducted by WOSCC Online Analysis Platform VOSviewer 1.6.16. In total, there were 169 945 authors 342 organizations 25 countries/regions, published in 111 journals. most productive country, organization, author, journal United States, University Southern California, Valter D. Longo, Nutrients, respectively. first high-cited document Ageing Research Reviews authored Mattson et al. this study, they discuss various health benefits including improved metabolic health, weight management, even potential delaying aging processes risk chronic diseases. conclusion, our main research hotspots frontiers cancer, metabolic-related diseases, cognitive improvement. may have some multiple diseases which should be further investigated.
Language: Английский
Citations
5Annals of Medicine, Journal Year: 2025, Volume and Issue: 57(1)
Published: March 11, 2025
Background Neutrophil extracellular trap (NET) correlate with chronic obstructive pulmonary disease (COPD) severity. Platelets can promote NET generation. However, serotonin alone or serotonin-deficient platelets do not adequately production. The metabolism of to 5-hydroxyindoleacetic acid (5-HIAA) in may be the key this difference.
Language: Английский
Citations
0Breast Cancer Research, Journal Year: 2025, Volume and Issue: 27(1)
Published: April 23, 2025
The mechanisms underpinning neoadjuvant chemotherapy-induced vascular endothelial injury in breast cancer remain elusive. Our study aims to demonstrate that Neutrophil Extracellular Traps (NETs) play a pivotal role cancer, elucidating upregulation of Solute Carrier 11a1 (Slc11a1) modulates Reactive Oxygen Species (ROS) generation, which may be critical for NETs formation. We investigated the impact chemotherapy on formation and by analyzing dsDNA serum markers patients, cells, mouse models. RNA sequencing neutrophils from models was performed identify potential formation-associated gene Slc11a1, further validated through cellular animal experiments assessing Slc11a1 expression, intracellular ferrous ion content, ROS levels. Knockdown human were also confirm phenotypic results. revealed plasma significantly elevated patients undergoing docetaxel & carboplatin (TCb) chemotherapy, compared controls. In these associated with augmentation markers. Chemotherapy demonstrated TCb treatment markedly injury, can mitigated CI-amidine, protein-arginine deiminase inhibitor. neutrophils, we chemotherapeutic agents (combination carboplatin) induced NETs, subsequently facilitated damage umbilical vein cells vitro. identified as key formation-related gene, upregulated leading increased content generation. its reversal effect TCb-induced upregulation, research underscores capacity augment Slc11a1-mediated is linked injury. elucidates underlying perioperative offering novel insights into therapeutic management strategies patients.
Language: Английский
Citations
0Experimental Neurology, Journal Year: 2024, Volume and Issue: 380, P. 114915 - 114915
Published: Aug. 8, 2024
Language: Английский
Citations
0European Journal of Immunology, Journal Year: 2024, Volume and Issue: 54(12)
Published: Sept. 12, 2024
G protein-coupled receptors (GPCRs) are vital cell surface that govern a myriad of physiological functions. Despite their crucial role in regulating antitumor immunity and tumorigenesis, therapeutic applications targeting GPCRs oncology currently limited. This review offers focused examination selected protumorigenic chemokine metabolite-sensing GPCRs. Specifically, the highlights five able to orchestrate tumor immunobiology at three main levels: immunity, cancer expansion, blood vessel development. The culminates by illuminating emerging therapies discussing innovative strategies harness full potential GPCR-targeted treatments, applying multireceptor patient-specific logic.
Language: Английский
Citations
0Phytomedicine Plus, Journal Year: 2024, Volume and Issue: unknown, P. 100649 - 100649
Published: Oct. 1, 2024
Language: Английский
Citations
0European Journal of Pharmacology, Journal Year: 2023, Volume and Issue: 964, P. 176295 - 176295
Published: Dec. 26, 2023
Language: Английский
Citations
1